Johnson & Johnson’s Fast-Acting Depression Drug Is Approved

(Bloomberg) -- Severely depressed patients will have a new, fast-acting treatment option after the U.S. approved a breakthrough drug that has the potential to upend how the condition is treated.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.